Spherical Nucleic Acids Deliver a New Package for Oliognucleotide Therapeutics
SNAs Are a Hopeful First Step in Boosting the Utility of Oligonucleotides to Treat a Variety of Human Diseases
Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
For full access to this article login to GEN Select now.
Regenerative Therapies Gain Momentum
Initiatives Include Treating Diseases and Conditions by Restoring or Repairing Genetic and Cellular Defects
- Advances in stem cell research and tissue engineering are evolving into a new generation of regenerative therapies to treat diseases and conditions by restoring or repairing genetic and cellular defects. The clinical development stakes are high, but the results have been some fruitful collaborations between pharma and biotech. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.